mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-07 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
5e-07 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
6e-07 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
7e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
9e-07 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
1e-06 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-06 |